Table 3 Vascular parameters among participants not using blood pressure-lowering medications
Unadjusted | Adjusted for age and sex | Adjusted for age, sex and, mean arterial pressurea | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NT | WH | MH | SH | NT | WH | MH | SH | NT | WH | MH | SH | |
(n = 194) | (n = 68) | (n = 38) | (n = 154) | (n = 194) | (n = 68) | (n = 38) | (n = 154) | (n = 194) | (n = 68) | (n = 38) | (n = 154) | |
Office PWV, m/s | 6.60 ± 1.69 | 7.63 ± 2.03* | 7.12 ± 1.89 | 7.80 ± 1.89* | 6.89 ± 0.05 | 7.53 ± 0.09* | 6.90 ± 0.12† | 7.54 ± 0.06*‡ | 7.31 ± 0.06 | 7.34 ± 0.08 | 7.12 ± 0.10 | 7.05 ± 0.07*† |
24 h PWV, m/s | 6.40 ± 1.64 | 6.90 ± 1.90 | 7.22 ± 1.98* | 7.35 ± 1.74* | 6.69 ± 0.04 | 6.80 ± 0.07 | 7.00 ± 0.09* | 7.09 ± 0.05*† | 6.94 ± 0.05 | 6.92 ± 0.07 | 6.81 ± 0.09 | 6.77 ± 0.06 |
Daytime PWV, m/s | 6.47 ± 1.63 | 6.99 ± 1.88 | 7.29 ± 1.94* | 7.44 ± 1.70* | 6.75 ± 0.04 | 6.89 ± 0.07 | 7.07 ± 0.09* | 7.19 ± 0.05*† | 6.99 ± 0.05 | 7.00 ± 0.06 | 6.90 ± 0.09 | 6.89 ± 0.06 |
Nighttime PWV, m/s | 6.29 ± 1.67 | 6.78 ± 1.95 | 7.09 ± 2.09 | 7.18 ± 1.84 | 6.58 ± 0.05 | 6.68 ± 0.07 | 6.87 ± 0.10* | 6.92 ± 0.05*† | 6.79 ± 0.05 | 6.77 ± 0.07 | 6.69 ± 0.10 | 6.66 ± 0.05 |
Office AIx | 24.1 ± 11.7 | 27.7 ± 10.7 | 25.2 ± 11.5 | 27.4 ± 11.6* | 23.8 ± 0.8 | 27.9 ± 1.3* | 25.7 ± 1.7 | 27.6 ± 0.8* | 25.2 ± 1.0 | 27.2 ± 1.3 | 26.5 ± 1.7 | 25.9 ± 1.1 |
24 h AIx | 22.1 ± 8.7 | 22.9 ± 8.9 | 23.9 ± 8.1 | 25.1 ± 8.7* | 21.9 ± 0.4 | 23.0 ± 0.7 | 24.3 ± 0.9* | 25.2 ± 0.5*† | 23.4 ± 0.5 | 23.7 ± 0.7 | 23.1 ± 1.0 | 23.2 ± 0.6 |
Daytime AIx | 23.1 ± 8.5 | 24.4 ± 8.4 | 25.4 ± 7.3 | 26.7 ± 8.4* | 22.7 ± 0.4 | 24.6 ± 0.7* | 26.0 ± 1.0* | 26.9 ± 0.5*† | 24.2 ± 0.5 | 25.2 ± 0.7 | 24.9 ± 1.0 | 25.1 ± 0.6 |
Nighttime AIx | 20.7 ± 11.2 | 20.8 ± 11.9 | 21.2 ± 10.6 | 22.3 ± 10.6 | 20.8 ± 0.6 | 20.8 ± 1.0 | 21.3 ± 1.3 | 22.1 ± 0.6 | 22.0 ± 0.6 | 21.3 ± 1.0 | 20.4 ± 1.3 | 20.7 ± 0.7 |